GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: CNTO-1959 | Tremfya®
                                 guselkumab is an approved drug (EMA & FDA (2017)) Compound class: 
                                                            Antibody
                                 
                                    
                                        Comment: Guselkumab is a monoclonal antibody directed against interleukin-23A (IL23A). It is being investigated as a treatment for plaque psoriasis. Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. | 
| Classification  | |
| Compound class | Antibody | 
| Approved drug? | Yes. EU EMA (2017) | US FDA (2017) | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 9774 | guselkumab | 
| Synonyms  | 
| CNTO-1959 | Tremfya® | 
| Database Links  | |
| Specialist databases | |
| IMGT/mAb-DB | 468 | 
| Other databases | |
| GtoPdb PubChem SID | 249565678 | 
| Search PubMed clinical trials | guselkumab | 
| Search PubMed titles | guselkumab | 
| Search PubMed titles/abstracts | guselkumab | 
| Wikipedia | Guselkumab |